Results 281 to 290 of about 155,399 (295)
Some of the next articles are maybe not open access.
Age-related macular degeneration
The Lancet, 2018Age-related macular degeneration is a leading cause of visual impairment and severe vision loss. Clinically, it is classified as early-stage (medium-sized drusen and retinal pigmentary changes) to late-stage (neovascular and atrophic). Age-related macular degeneration is a multifactorial disorder, with dysregulation in the complement, lipid, angiogenic,
Paul, Mitchell +3 more
openaire +2 more sources
Neovascular Age-Related Macular Degeneration
Ophthalmologica, 2012<i>Purpose:</i> Neovascular age-related macular degeneration (AMD) is a leading cause of blindness, with an increasing incidence as the elderly population expands. Large, multi-center, randomized, clinical trials have been conducted exploring the safety and efficacy of anti-VEGF treatments. This paper aims to discuss the safety and efficacy
VERITTI, Daniele +2 more
openaire +2 more sources
Cystoid Macular Degeneration in Exudative Age-Related Macular Degeneration
American Journal of Ophthalmology, 2011To investigate the prevalence and clinical significance of cystoid macular degeneration in eyes that underwent intravitreal ranibizumab injections for exudative age-related macular degeneration.Retrospective, interventional case series.We reviewed the charts of 56 consecutive patients (19 male, 37 female; mean age ± standard deviation, 80.81 ± 4.8 ...
QUERQUES , GIUSEPPE +5 more
openaire +4 more sources
Macular dystrophies mimicking age-related macular degeneration
Progress in Retinal and Eye Research, 2014Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the elderly population in the Western world. AMD is a clinically heterogeneous disease presenting with drusen, pigmentary changes, geographic atrophy and/or choroidal neovascularization.
Saksens, N.T.M. +12 more
openaire +4 more sources
Age-Related Macular Degeneration
Primary Care: Clinics in Office Practice, 2015Age-related macular degeneration (AMD) is the leading cause of vision loss in the elderly. AMD is diagnosed based on characteristic retinal findings in individuals older than 50. Early detection and treatment are critical in increasing the likelihood of retaining good and functional vision.
openaire +2 more sources
Nonneovascular Age-Related Macular Degeneration
2015The discovery of several genetic variants associated with an increased risk for age-related macular degeneration (AMD) has led to a completely new understanding of AMD. In addition to the known modifiable risk factors, genetic risk factors may also help to assess the risk to progress to nonneovascular AMD.
Stephan, Michels, Gerhard, Garhöfer
openaire +2 more sources
Neovascular Age-Related Macular Degeneration
2015Age-related macular degeneration (AMD) is the leading cause of severe vision loss in individuals over the age of 50 years. Choroidal neovascularization (CNV) is the hallmark of 'wet' or 'exudative' AMD, and is responsible for approximately 90% of cases of severe vision loss due to AMD. Vascular endothelial growth factor (VEGF) is a key component in the
Jack, Shao +2 more
openaire +2 more sources
Age‐related macular degeneration in Inuit
Acta Ophthalmologica Scandinavica, 1999To describe a specific Greenlandic type af age-related macular degeneration (AMD) - the Retinochoroidal Atrophy (RCA).135 referred patients in East Greenland were examined in 1997. A colour and a redfree fundus photograph of an 87-year-old Greenlandic woman illustrates the clinical picture of RCA (retinochoriodal atrophy).Of 135 examined patients 22 ...
openaire +3 more sources
Age-related macular degeneration
British Journal of Hospital Medicine, 2016B B, Ong, F G, Ah-Fat
openaire +2 more sources
Age-Related Macular Degeneration
New England Journal of Medicine, 2000S L, Fine +3 more
openaire +2 more sources

